TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07579429: Research On Nicotinamide Riboside Supplement Support in MDS (ROSS Trial)

Sponsor: University of Colorado, Denver · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 20 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$2,988,000

Rescue Site Savings

+$1,958,800

Unlock Full NCT07579429 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07579429 Rescue Dossier →